We evaluated this ELISA against 3 business MOMP peptide ELISA assays, using sera from 164 females who was simply infected withC. where seroprevalence reduced from 21% in 2007 to 9% this year 2010 (p = 0.002). These seroprevalence data reveal some known top features of the epidemiology of chlamydia an Continue Reading